Lineage Cell Therapeutics
LCTX
$1.05
Share price
-7.08%
Change (1 day)
-19.85%
Change (1 year)
Categories
Lineage Cell Therapeutics (LCTX) - P/B ratio
P/B ratio as of May 2024 : 3.43
According to Lineage Cell Therapeutics
's latest financial reports the company has a price-to-book ratio of 3.43.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lineage Cell Therapeutics - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.08 | 11.24% |
| 2022-12-31 | 2.76 | -39.15% |
| 2021-12-31 | 4.54 | 63.71% |
| 2020-12-31 | 2.78 | 131.55% |
| 2019-12-31 | 1.20 | -4.76% |
| 2018-12-31 | 1.26 | -24.22% |
| 2017-12-31 | 1.66 | -41.59% |
| 2016-12-31 | 2.84 | -41.38% |
| 2015-12-31 | 4.85 | 4.24% |
| 2014-12-31 | 4.65 | -3.71% |
| 2013-12-31 | 4.83 | -24.31% |
| 2012-12-31 | 6.38 | -9.36% |
| 2011-12-31 | 7.04 | -6.69% |
| 2010-12-31 | 7.55 | -41.46% |
| 2009-12-31 | 12.9 | -233.06% |
| 2008-12-31 | -9.69 | 212.4% |
| 2007-12-31 | -3.10 | -3.3% |
| 2006-12-31 | -3.21 | -90.9% |
| 2005-12-31 | -35.2 | -145.16% |
| 2004-12-31 | 78.0 | -1106.2% |
| 2003-12-31 | -7.75 | -58.45% |
| 2002-12-31 | -18.7 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.81 | -18.28% | 🇺🇸 USA |